IOL evolution for presbyopia

Article

“As we move into the 21st century the role of the IOL will evolve allowing better outcomes in cataract surgery and find new roles in surgery to improve vision such as through the treatment of presbyopia.”

“As we move into the 21st century the role of the IOL will evolve allowing better outcomes in cataract surgery and find new roles in surgery to improve vision such as through the treatment of presbyopia.” This was the view of Consultant Ophthalmic Surgeon, Queen's University Hospital, London, Mr. Charles Claoué on the news that the pioneering and sole British manufacturer of IOLs, Rayner Intraocular Lenses Ltd., has been awarded the prestigious Queen's Award for Enterprise.

“This recognition is well-deserved. Rayner is the most dynamic and innovative IOL company in the world and has a glorious history including having made the first ever IOL. At a time of global financial stress it is impressive for a British company to be achieving so much and excelling in the world marketplace.”

Rayner has advanced from making only monofocal lenses for cataract to excelling in toric and multifocal lens design. In the UK, premium multifocal IOLs treat presbyopia and are currently only available in private practice, for a cost of approximately £2,500 per eye, with no option to top-up from NHS–funded cataract surgery. Rayner's multifocal IOLs permit focus for long, intermediate and short distances. Patients report an average vision score of 92% following implantation of an IOL, where 100' would mean no disability. Rayner also remains committed to researching new biomaterials that offer exciting possibilities for future IOL development.

“We are a British manufacturer that is proud of the fact that we have refused to shift manufacture overseas but instead take our products to these markets and succeed. In Russia, Korea, Brazil, India, USA, Germany and many other countries we win by finding excellent local business partners, teaming up with their eye surgeon-customers and bringing internationally renowned surgeons from one country to another, passing on skills and exchanging clinical results. This week it is a tour of four Chinese cities where we are hosting educational seminars for audiences of hundreds of eye surgeons wanting to learn more about our lenses, especially the multifocal and multifocal toric lenses,” said Donald J. Munro, chairman and managing director of Rayner.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.